David Gitlin

Shareholder
Philadelphia,  PA  U.S.A.
Phone215.988.7850

Peer Rating
 5.0/5.0
AV® Preeminent

Client Rating

Featured AV Peer Review Rated Lawyer IconFeatured AV Peer Review Rated Lawyer Icon
Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials Ratings & Reviews
 

Practice Areas

  • Corporate & Securities
  • Emerging Technology
  • Private Equity
  • Life Sciences & Medical Technology
 
Contact InfoTelephone: 215.988.7850
Fax: 215.988.7801
http://www.gtlaw.com/People/David-Gitlin
 
Law SchoolTel Aviv University, Faculty of Law, J.D., with honors, 1979; University of Pennsylvania Law School, LL.M., with honors, 1981 Recipient, Gowen Award
 
Admitted1981, New York; 1983, Pennsylvania; 1984, Israel
 
Memberships 

Professional & Community Involvement

•Chair, Bnai Zion Foundation, Mid-Atlantic

•Past President, America-Israel Chamber of Commerce, Mid-Atlantic Chapter

 
LanguagesHebrew, Fluent; Spanish, Fluent
 
Biography

David Gitlin focuses his practice on corporate and securities, with an emphasis on mergers and acquisitions, venture capital, technology development, and corporate finance. For more than 30 years, David has counseled foreign clients doing business in the United States and U.S. clients doing business abroad. He has structured more than 200 M&A deals, more than half of which have been cross-border transactions involving leading businesses in Finland, India, Israel and Sweden, among others. He has represented U.S. clients in the purchase or sale of businesses in more than 15 countries.

David represents both U.S. and foreign venture capital funds, and has handled numerous technology development transactions, including licensing, distribution and joint venture agreements, as well as collaborations between industry and academia.

David is recognized by Chambers USA Guide as a leading M&A attorney, and is nationally ranked as a leading Venture Capital attorney. In 2005, he was recognized by the mayors of Philadelphia and Tel Aviv for exceptional accomplishments in developing business opportunities for Israeli companies in the United States.

Prior to joining the firm, David was partner in the corporate practice of a large, multidisciplinary law firm. He also practiced at a Philadelphia-based law firm, where he chaired the corporate/securities practice group and was a member of the firm's executive committee.

Areas of Concentration

#8226;Mergers and acquisitions, and private equity

#8226;Venture capital and emerging technologies

#8226;Energy and clean tech

#8226;Technology

#8226;Life sciences

Significant Representations

#8226;Represented Consol Energy, Inc. in a $3.5 billion sale of Consolidation Coal Company to a subsidiary of Murray Energy Corporation.

#8226;Represented publicly traded Finnish manufacturing company in its acquisition of a division of a large U.S. company, including the purchase of stock and assets of subsidiaries located in the United States and five foreign countries, and the coordination of closings in different countries across different calendar years.

#8226;Represented multinational publicly traded Swedish manufacturing company in its acquisition of a division of a Fortune 500 company, including the purchase of stock and assets of subsidiaries located in 12 different countries.

#8226;Represented multinational publicly traded Indian company in the acquisition of a California corporation. The transaction included particularly complex regulatory matters specific to the defense industry as well as cross-border employee benefit issues.

#8226;Represented Nasdaq-traded CRO in the acquisition of a Finnish corporation for a combination of cash and stock. The transaction involved complex cross-border securities issues.

#8226;Represented Israel-based provider of application problem resolution software in its acquisition by a large U.S. software company, structuring and negotiating a complex stock purchase agreement that incorporated the use of a novel statutory take along provision.

#8226;Represented Israel-based leading manufacturer of armored equipment in its acquisition of a Michigan-based defense contractor.

#8226;Represented Mid-Atlantic late-stage venture fund in an investment in a rapidly expanding provider of medical market research.

#8226;Represented U.S.-based biotech company in a Series B round investment that was led by a Swiss-based, global life sciences fund and a leading California-based life sciences investment firm.

#8226;Represented Swiss-based, global life sciences fund in a Series B investment in a biotechnology company engaged in the development of novel products for the treatment of metabolic diseases.

#8226;Represented U.S.-based corporation engaged in the development of alternative energy sources in a significant investment by a leading Israeli private equity fund.

#8226;Represented Israeli-based biotech company in a worldwide license and distribution agreement with a leading Italian pharma company.

The above representations were handled by Mr. Gitlin prior to his joining Greenberg Traurig, LLP.

Awards & Recognition

#8226;Listed, Chambers USA Guide, 2007-2014

#8226;#8226;Pennsylvania, Corporate M&A and Private Equity, 2007-2014

#8226;#8226;Nationwide, Investment Funds and Venture Capital, 2012-2013

#8226;Team Member, Corporate Board Member magazine and FTI Consulting Inc., one of America's Best Corporate Law Firms, 13th Annual Legal Industry Study, 2013

#8226;Recipient, Distinguished Humanitarian Award, Bnai Zion Foundation, 2010

#8226;Rated, AV Preeminent 5.0 out of 5

AV, BV, AV Preeminent and BV Distinguished are registered certification marks of Reed Elsevier Properties Inc., used under in accordance with the Martindale-Hubbell certification procedures, standards and policies.

Articles, Publications, & Lectures

#8226;Mentioned, Sealing The Deal: Greenberg Guides Consol's $3.5B Mine Sale, Law360, December 3, 2013

#8226;Mentioned, Murray's $3.5B Consol Coal Mines Buy Gets Antitrust OK, Law360, December 3, 2012

#8226;Mentioned, New Deal: Five Firms Advise $3.5 Billion Sale of W. Va. Coal Mines by Consol, New York Law Journal, October 31, 2013

#8226;Mentioned, Greenberg Among Firms on Consol Deal: Business of Law, Bloomberg, October 29, 2013

#8226;Mentioned, Five Firms Advise on $3.5 Billion Consol Coal Mine Deal, The American Lawyer, October 28, 2013

Associated News & Events

Press Releases

06.02.14 Three Greenberg Traurig Pennsylvania Attorneys Included in 2014 Chambers USA Guide

05.23.14 Greenberg Traurig Attorneys, Practices Included in 2014 Chambers USA Guide

05.16.14 Greenberg Traurig is Lead Sponsor for The MIXiii Israel Innovation Conference

05.28.13 Chambers USA Guide 2013 Includes 175 Greenberg Traurig Attorneys, 33 Practice Areas

06.01.12 Greenberg Traurig Continues Expansion of Israel Practice with Addition of Two Attorneys

05.31.12 Prominent M&A Attorney David Gitlin Joins Greenberg Traurig in Philadelphia

 
Reported CasesSignificant Representations; Represented Consol Energy, Inc. in a $3.5 billion sale of Consolidation Coal Company to a subsidiary of Murray Energy Corporation. Represented publicly traded Finnish manufacturing company in its acquisition of a division of a large U.S. company, including the purchase of stock and assets of subsidiaries located in the United States and five foreign countries, and the coordination of closings in different countries across different calendar years. Represented multinational publicly traded Swedish manufacturing company in its acquisition of a division of a Fortune 500 company, including the purchase of stock and assets of subsidiaries located in 12 different countries. Represented multinational publicly traded Indian company in the acquisition of a California corporation. The transaction included particularly complex regulatory matters specific to the defense industry as well as cross-border employee benefit issues. Represented Nasdaq-traded CRO in the acquisition of a Finnish corporation for a combination of cash and stock. The transaction involved complex cross-border securities issues. Represented Israel-based provider of application problem resolution software in its acquisition by a large U.S. software company, structuring and negotiating a complex stock purchase agreement that incorporated the use of a novel statutory take along provision. Represented Israel-based leading manufacturer of armored equipment in its acquisition of a Michigan-based defense contractor. Represented Mid-Atlantic late-stage venture fund in an investment in a rapidly expanding provider of medical market research. Represented U.S.-based biotech company in a Series B round investment that was led by a Swiss-based, global life sciences fund and a leading California-based life sciences investment firm. Represented Swiss-based, global life sciences fund in a Series B investment in a biotechnology company engaged in the development of novel products for the treatment of metabolic diseases. Represented U.S.-based corporation engaged in the development of alternative energy sources in a significant investment by a leading Israeli private equity fund. Represented Israeli-based biotech company in a worldwide license and distribution agreement with a leading Italian pharma company.
 
ISLN907075675
 


View Ratings & Reviews
Profile Visibility
#1,570 in weekly profile views out of 15,817 lawyers in Philadelphia, Pennsylvania
#129,265 in weekly profile views out of 1,568,853 total lawyers Overall

Office Information

David Gitlin

2001 Market Street
PhiladelphiaPA 19103




Loading...
 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now